All
Tazverik a Safe and Effective Option for Heavily Pretreated Patients with Follicular Lymphoma
October 27th 2020In addition to showing clinically meaningful, durable responses, Tazverik (tazemetostat) was generally well-tolerated in heavily pretreated patients with relapsed or refractory follicular lymphoma, according to the results of an open-label, single-arm, multicenter phase 2 study.
Patients with Cancer Stand to Lose if Supreme Court Repeals ‘Obamacare’
October 27th 2020Justice Amy Coney Barrett was sworn in to the Supreme Court on Tuesday. Her vote would be instrumental in deciding the fate of the Affordable Care Act. If it’s repealed during November’s landmark case, many could lose access to cancer screening and treatment.
Adding Darzalex to Standard Treatment for High-Risk Multiple Myeloma May Delay Disease Progression
October 27th 2020A meta-analysis of six clinical trials showed that standard treatment regimens for high-risk multiple myeloma may be more effective at delaying disease progression if they are given in combination with the targeted drug Darzalex (daratumumab).
People Who Have Cancer Can Leave Behind a Couple Kinds of Legacies
October 21st 2020“The future is not yours,” says Pam Haldeman, who has metastatic breast cancer. “A way to get back a little bit of control is to be your own advocate and get aggressive in researching and going to every conference or retreat available.”